Cabell County Commission v. Amerisourcebergen Drug Corporation

  1. March 18, 2024

    4th Circ. Sends Opioid 'Nuisance' Question To W.Va. Top Court

    The Fourth Circuit asked West Virginia's high court Monday to determine whether the state's public nuisance law can be used to target companies that shipped drugs to pharmacies in a community ravaged by addiction, a crucial question in litigation spawned by the opioid crisis.

  2. January 25, 2024

    Opioid Nuisance Query Better For W.Va. Court, 4th Circ. Hints

    A Fourth Circuit panel asked repeatedly Thursday why no one had sought help from West Virginia's high court in a bellwether legal clash over whether anti-nuisance laws can be used to target the drug companies that supplied pharmacies amid the opioid crisis.

  3. May 02, 2023

    Reject 'Carte Blanche' For Risky Opioid Sales, 4th Circ. Urged

    A West Virginia city and county have told the Fourth Circuit that distributors of addictive painkillers misinterpreted state nuisance law and the federal Controlled Substances Act when seeking to uphold a lower court's dismissal of the local governments' multibillion-dollar opioid lawsuit.

  4. April 19, 2023

    Distributors Push 4th Circ. To Uphold Opioid Verdict

    Drug distributors AmerisourceBergen, Cardinal Health and McKesson on Wednesday urged the Fourth Circuit not to overturn a verdict in a West Virginia opioid case, saying that the volume of opioids they were shipping increased because doctors' standards of care for pain treatment changed.

  5. April 18, 2023

    W.Va. County Urges 4th Circ. To Revive Opioid Distributor Row

    A West Virginia county has asked the Fourth Circuit to overturn the rejection of multibillion-dollar opioid litigation that it says let distributors off the hook for excessive painkiller shipments, saying a trial judge wrongly applied the state's public nuisance law.

  6. March 24, 2023

    Opioid Theory Reaches 'Alcohol, Guns, Phones,' 4th Circ. Told

    A West Virginia federal judge's monumental rejection of a multibillion-dollar opioid case correctly avoided a "dramatic rewriting" of state law that would threaten legal exposure for sellers of liquor, cellphones, firearms and other lawful products, drug distributors told the Fourth Circuit on Friday.

  7. January 03, 2023

    Health & Pharma Legal Clashes Didn't Take A Holiday Break

    While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.